Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3578302
Max Phase: Preclinical
Molecular Formula: C19H22Cl2N2O4
Molecular Weight: 413.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3578302
Max Phase: Preclinical
Molecular Formula: C19H22Cl2N2O4
Molecular Weight: 413.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: OCC(CO)(CO)NCC(O)Cn1c2ccc(Cl)cc2c2cc(Cl)ccc21
Standard InChI: InChI=1S/C19H22Cl2N2O4/c20-12-1-3-17-15(5-12)16-6-13(21)2-4-18(16)23(17)8-14(27)7-22-19(9-24,10-25)11-26/h1-6,14,22,24-27H,7-11H2
Standard InChI Key: GETQKLUOZMYHGE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 413.30 | Molecular Weight (Monoisotopic): 412.0957 | AlogP: 1.77 | #Rotatable Bonds: 8 |
Polar Surface Area: 97.88 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.97 | CX Basic pKa: 8.34 | CX LogP: 1.44 | CX LogD: 0.45 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.39 | Np Likeness Score: -0.52 |
1. Hurley KA, Heinrich VA, Hershfield JR, Demons ST, Weibel DB.. (2015) Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria., 6 (4): [PMID:25941556] [10.1021/acsmedchemlett.5b00024] |
Source(1):